K
51
-2
INTU
56
3
VRTX
52
-2
GILD
54
-2
FLR
50
-2
C
62
-2
HRL
45
-2
FE
45
-3
FDX
30
-7
SYY
53
-3
JBHT
58
-5
GE
67
2
HBAN
54
-2
MDT
63
-3
HPQ
53
-3
LEG
43
-4
PM
58
-2
CMG
66
2
EXR
57
-5
SWK
62
-5
K
51
-2
INTU
56
3
VRTX
52
-2
GILD
54
-2
FLR
50
-2
C
62
-2
HRL
45
-2
FE
45
-3
FDX
30
-7
SYY
53
-3
JBHT
58
-5
GE
67
2
HBAN
54
-2
MDT
63
-3
HPQ
53
-3
LEG
43
-4
PM
58
-2
CMG
66
2
EXR
57
-5
SWK
62
-5
Financhill
Back

Janux Therapeutics Vs. Galectin Therapeutics Industry Stock Comparison

Sell
34

JANX
Janux Therapeutics

Last Price:
66.94
Seasonality Move:
133.13%
Sell
46

GALT
Galectin Therapeutics

Last Price:
2.34
Seasonality Move:
36.88%
Sell
34
Janux Therapeutics (JANX) is a Sell

Is Janux Therapeutics a Buy, Sell or Hold?

  • The current Janux Therapeutics [JANX] share price is $59.86. The Score for JANX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • JANX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Galectin Therapeutics (GALT) is a Sell

Is Galectin Therapeutics a Buy, Sell or Hold?

  • The current Galectin Therapeutics [GALT] share price is $2.60. The Score for GALT is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • GALT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

JANX Stock Price Chart

What is Janux Therapeutics's stock price today?

  • The Janux Therapeutics share price today is $59.86
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JANX is experiencing selling pressure, which indicates risk of future bearish movement.

GALT Stock Price Chart

What is Galectin Therapeutics's stock price today?

  • The Galectin Therapeutics share price today is $2.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GALT is experiencing selling pressure, which indicates risk of future bearish movement.

JANX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.63 Sell
Relative Strength Index (14 RSI): 63.62 Buy
Chaikin Money Flow: -6955717 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (47.07 - 55.53) Buy
Bollinger Bands (100): (41.63 - 51.75) Buy

GALT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 43.31 Sell
Chaikin Money Flow: -443838 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.6 - 2.88) Sell
Bollinger Bands (100): (2.36 - 2.8) Buy

JANX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 48.16 Buy
20-day SMA: 50.4 Buy
50-day SMA: 49.88 Buy
200-day SMA: 44.87 Buy
8-day EMA: 49.16 Buy
20-day EMA: 49.72 Buy
50-day EMA: 49.41 Buy
200-day EMA: 41.75 Buy

GALT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.76 Sell
20-day SMA: 2.79 Sell
50-day SMA: 2.69 Sell
200-day SMA: 2.63 Sell
8-day EMA: 2.76 Sell
20-day EMA: 2.75 Sell
50-day EMA: 2.7 Sell
200-day EMA: 2.52 Buy

Janux Therapeutics Earnings Growth & JANX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and a decrease next year of $0.91 per share.

Galectin Therapeutics Earnings Growth & GALT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Janux Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Galectin Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):